Adinazolam resources

DRUG INFO
Adinazolam

Drug Name: Adinazolam


Indication: For treatment of panic disorder



Pharmacology: Adinazolam is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Adinazolam binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.

Mechanism Of Action: Adinazolam binds to peripheral-type benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.

Drug Category: Antidepressants; ATC:N05BA07

Brand Names/Synonyms: ADINAZOLAM; Adinazolam [Usan:Ban:Inn]; Adinazolam [Usan]; Adinazolamum [Inn-Latin]; U 41123

Dosage Forms: Not Available

Absorption: Not Available

Interactions: DrugBank: Interactions for Adinazolam

Interactions for Adinazolam:


Co-administration with antifungal agents such as ketoconazole or itraconazole is not recommended. Nafazodone, fluvoxamine, cimetidine (consider Xanax dose reduction). Fluoxetine, OCs, sertraline, diltiazem, macrolide antibiotics (exercise caution).



Chemical IUPAC Name: Not Available

Chemical Formula: C19H18ClN5

Half Life: Not Available

Drug Type: Approved Drug

# Accession No: APRD00724

CAS Registry Number: 37115-32-5